Reimbursement
The approach of MACRA promises sweeping change to healthcare providers. Experts in the field weigh in on what the regulatory implications really mean for providers and how to prepare.
Six new standardized plan designs will eliminate many of the moving parts that have bedeviled consumers trying to make apples-to-apples comparisons between plans.
Separate study says 45 percent may be a low estimate and number could be closer to 65 percent.
Mylan said Monday it will offer a generic version of the life-saving allergy treatment following weeks of criticism over price hike.
In the fall issue of the Journal of American Physicians and Surgeons, Ophthalmologist Kristin S. Held writes MACRA is not a step forward, but is "a more elaborate system of price controls."
American Hospital Association is urging HHS to take measures to stabilize the Affordable Care Act's marketplaces, saying some insurers' decisions to exit put consumers' access at risk.
Programs substantially cut the risk of dying from another cardiac problem, improve quality of life and lower costs; less than one-third of patients whose conditions qualify for the rehab actually participate.
Mylan CEO Heather Bresch calls new option "an extraordinary commercial response" following rising backlash from public, lawmakers on price hike.
Patient advocates have argued that follow-up colonoscopies should be provided without cost sharing by patients; awareness can help patients prepare for facility fees.
Legislation also would require the nation's first minimum nurse-to patient staffing ratios in observation care units.